Tag: Mumps
Waning Immunity Most Consistent With Recent Mumps Outbreaks
Estimated 32.8 percent of individuals lose vaccine-derived immunity by age 18 years in the United States
PRIORIX, M-M-R II Vaccines Interchangeable for MMR
Either PRIORIX or M-M-R II may be administered in any situation in which MMR vaccine is indicated
Almost One-Third of Mumps Cases in U.S. Occur in Children, Teens
Median of 87 percent of the pediatric patients each year had previously received one or more MMR vaccine dose
Many Cancer Patients Lack Immunity for Measles, Mumps
Overall seroprevalence of measles and mumps antibodies 0.75 and 0.62 for ambulatory cancer patients
2.3 Percent of Kindergarteners Not Up to Date With MMR in 2019-2020
2.5 percent of kindergartners had an exemption, but additional 2.3 percent were not up to date and had no exemption
Pandemic-Related MMR Vaccine Decline Persists
Authors say catch-up strategies are necessary to ensure young children receive preventive care
Review: MMR, MMRV, MMR+V Vaccines Are Effective, Safe
Review confirms vaccines effective for preventing disease, not associated with increased risk for autism
Decreased Humoral Immunity to Mumps Seen in Young Adults
10 percent of college-aged students vaccinated in childhood had no detectable memory B cells to mumps
CDC: Mumps Outbreak Reported in Migrant Detention Facilities
898 confirmed, probable mumps cases reported in adult migrants detained in 57 facilities
Mumps Outbreak at Temple University Reaches 74 Cases
University and local health department working together to combat outbreak
